Introduction
Mouse spleen lymphocytes in serum-free culture are stimulated by the plant lectin concanavalin A to increase the rate of DNA synthesis by as much as lOOO-fold over the rate in resting cultures [ 1, 2] . Lectin stimulation of lymphocytes may be analogous to immunological activation [ 31. The ability to activate lymphocytes in serum-free culture provides an excellent system for studying G,-G,-S transitions of the cell cycle [ 41.
Previous observations in this and other laboratories have shown that cyclic AMP and its permeable derivatives are inhibitory to lymphocyte activation [1, 2, 4, 5] .
The work described in this communication implicates the involvement of 3/3-OH sterols and fatty acids in lymphocyte activation and suggests that cyclic AMP may exert metabolic regulation on pathways of acetate metabolism during lymphocyte activation.
Materials and Methods
Spleen cells from C3H-F mice were prepared as described by Chambers et al. [l] . Freshly dissected spleen cells were washed three times in phosphatebuffered saline and then suspended in serum-free RPM1 1640 (obtained from the University of California Cell Culture Facility, San Francisco) containing antibiotics, at an initial cell density of 5 -lo6 cells/ml. The lymphocyte cultures were incubated at 37°C in a humidified 5% COJ95% air atmosphere. An initial decline in cell number was observed during the first lo-20 h in the serum-free cultures but no further change in viability, as determined by the ability of cells to exclude Trypan blue, was seen during the course of the experiment. Cell viability remained constant at approx. 3 -10" cells/ml. Cultures were activated with concanavalin A (0.5 Erg/ml from Miles-Yeda, Elkhart, Ind.). This concentration of concanavalin A was found to be maximally stimulatory as reported previously [ 11. Concentrations of concanavalin A greater than 1 pg/ml in serum-free culture resulted in increased cellular toxicity. Dibutyryl cyclic AMP (obtained from the Sigma Chemical Co., St. Louis, MO.) was maximally inhibitory at concentrations greater than 2 -10m4 M, and was routinely used at 5 -10m4 M. This concentration of cyclic nucleotide has no effect on cell viability. [6] . Each data point represents the mean value of triplicate cultures, and each experiment was repeated at least three times.
Results
The temporal study of [3H]thymidine incorporation into DNA ( Fig. 1 ) showed that DNA synthesis began to increase about 20 h after concanavalin A addition. This finding is in agreement with observations by Loeb et al. [7] . The rate of synthesis continued to increase for at least 65 h, at which point the experiment was terminated. When dibutyryl cyclic AMP (5 - Parallel experiments designed to demonstrate the rates of ["Clacetate incorporation into sterols, fatty acids and CO* were performed. Concanavalin A addition to lymphocyte cultures resulted in enhanced sterols synthesis and this enhancement occurred prior to concanavalin A-induced DNA synthesis ( Fig. 2A) . The rate of sterol synthesis continued to increase in a linear fashion for at least 65 h (Fig. 2B) . Dibutyryl cyclic AMP added concomitantly with con~nava~~ A resulted in a reduction in the rate of [14C]acetate incorporation into sterol. The extent of inhibition at 45 h was 84%. The rate of [ "C]acetate incorporation into sterol did not change for resting cultures containing dibutyryl cyclic AMP ( Figs. 2A and 2B) . The results shown in Fig. 2A fatty acids after the addition of concanavalin A to lymphocyte cultures. By 22 h, the rate of concanavalin A-stimulated fatty acids synthesis was 20-fold greater than the resting rate and was maintained at this elevated rate up to 65 h. (Fig. 4) . However, CO* production gradually decreased under all experimental conditions and the cause of this decrease is not clear. The situation could be explained by a decrease in the rate of metabolism of acetate through the tricarboxylic acid cycle, in cells maintained in serum-free media. If this hypothesis is valid, the fall in COz production is apparently independent of concanavalin A-mediated effects on fatty acid and sterol biosynthesis.
In order to provide further insight into the nature of the cyclic AMP response, we have examined the temporal relationship of dibutyryl cyclic AMP addition to concanavalin A-stimulated lymphocytes with respect to fatty acid synthesis, sterol synthesis and DNA synthesis. The observations noted above, suggested a sequential order for cyclic AMP effects on these metabolic processes. The data of Fig. 5 demonstrate the effects of delayed addition of dibutyryl cyclic AMP on concanavalin A-stimulated DNA, fatty acid and sterol synthesis. A study of DNA synthesis revealed that when dibutyryl cyclic AMP was added concomi- tantly with concanavalin A, a maximal inhibition of 90% occurred, as observed in previous work with Balb/C mice [ 11. When dibutyryl cyclic AMP was added 2-6 h after concanavalin A, maximal inhibition was still observed. However, additions of dibutyryl cyclic AMP after 6 h resulted in decreased inhibition with time. Similar effects were observed for fatty acid and sterol synthesis, but in these cases maximum inhibition occurred only when dibutyryl cyclic AMP was added at 2 h or before. After 2 h, the inhibitory effects declined gradually as a function of the time of dibutyryl cyclic AMP addition.
The observed effects of delayed addition of dibutyryl cyclic AMP on mitogen-induced DNA synthesis are in agreement with the report of Smith et al. [8] , who concluded that dibutyryl cyclic AMP acts at an early phase of lymphocyte transformation; this also compliments previous observations in this laboratory [ 41. Our data demonstrate that dibutyryl cyclic AMP inhibits sterol and fatty acid synthesis early in the G, phase of lymphocyte transformation.
Discussion
The data presented in this study show that concanavalin A activation of mouse spleen lymphocytes is accompanied by a pronounced increase in both 3&OH sterol and fatty acid synthesis. Sterol synthesis increases at least 8 h before DNA synthesis. Fatty acid synthesis increases before sterol synthesis. Dibutyryl cyclic AMP inhibits the biosynthesis of all three of these products.
The decreasing effect of dibutyryl cyclic AMP when added at times after concanavalin A supports the hypothesis by Gunther et al. [9] that the cells, or subpopulation of cells, are sequentially committed to activation in the presence of lectin.
An argument consistent with the data presented above is that dibutyryl cyclic AMP inhibition of DNA synthesis is not tightly coupled to parallel regulation of fatty acid and sterol biosynthesis but that DNA synthesis has a requirement for enhanced fatty acid and/or sterol biosynthesis. Alternatively, dibutyryl cyclic AMP may regulate different events in the proliferative program in parallel. Nevertheless, the hypothesis by Chen et al.
[lo] that increased sterol synthesis may be a prerequisite for DNA synthesis in mitogen-stimulated lymphocytes is supported by this data. The possibility exists that the inhibitory effect of dibutyryl cyclic AMP on DNA synthesis may relate to prior inhibition of sterol or fatty acid synthesis, and that the synthesis of sterol or its precursors may be important in the regulation of the cell's proliferative program.
